Dimerix Limited (AU:DXB) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dimerix Limited is set to host a webinar on November 6, 2024, to discuss initial findings from Project PARASOL, which aims to advance FSGS treatment by exploring new biomarker-based endpoints. This initiative could potentially accelerate approval pathways for FSGS therapies, addressing a significant need in the market with no currently approved treatments. The webinar is expected to attract interest from stakeholders keen on the latest developments in kidney disease research.
For further insights into AU:DXB stock, check out TipRanks’ Stock Analysis page.